NanoViricides(NNVC)

Search documents
NanoViricides discusses lead program and next steps
Proactiveinvestors NA· 2024-07-11 13:02
Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research Read more Proactive has always been a forward looking and enthusiastic technology adopter. About this content About the publisher Proactive news team spans the world's key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. The team delivers news and unique insights across the market including but not co ...
NanoViricides hails broad potential of lead antiviral drug as it prepares to begin first Phase II trial
Proactiveinvestors NA· 2024-07-01 14:57
About Oliver Haill Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists. The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies. ...
NanoViricides hails the potential of NV-387 in combatting bird flu virus H5N1
Proactiveinvestors NA· 2024-06-24 12:37
Group 1 - Proactive is a forward-looking company that embraces technology and automation, including generative AI, while ensuring all content is edited and authored by humans [2][5]. - The company operates a global network with bureaus and studios in major financial hubs such as London, New York, Toronto, Vancouver, Sydney, and Perth [4]. - Proactive's editorial team produces a significant volume of content, creating approximately 50,000 pieces of news, feature articles, and filmed interviews annually [3]. Group 2 - The financial news and online broadcast teams at Proactive focus on delivering fast, accessible, and actionable business and finance news to a global investment audience [6]. - Proactive covers a wide range of sectors, including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [7]. - The company’s content creators possess extensive expertise and experience, utilizing technology to enhance their workflows [8].
NanoViricides says antiviral drug candidate shows promise in protecting lungs against Influenza A
Proactiveinvestors NA· 2024-06-20 13:38
Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The Canberra Times, and... Read more Abou ...
NanoViricides antiviral candidate 'may be first effective oral nanomedicine'
Proactiveinvestors NA· 2024-06-11 13:01
Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup News Service, Gracenote... Read more Abou ...
NanoViricides CEO says lead asset NV-387 could be ‘holy grail' of antiviral medicines
proactiveinvestors.com· 2024-05-29 12:38
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
NanoViricides reports strong antiviral activity of NV-387 against RSV
proactiveinvestors.com· 2024-05-20 12:16
About this content About Proactive Use of technology Proactive leads the world in up-to-the-minute, multi-media news provision, events organisation, investor relations management and investor research Read more Proactive has always been a forward looking and enthusiastic technology adopter. Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows. About the publisher Proactive news team sp ...
NanoViricides(NNVC) - 2024 Q3 - Quarterly Report
2024-05-15 00:25
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 1320 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the quarterly period ended March 31, 2024 Commission File Number: 001-36081 NANOVIRICIDES, INC. (Exact name of Company as specified in its charter) of incorporation or organization) Delaware 76-0674577 (State or other jurisdiction) (IRS Employer Identification No.) 1 Controls Drive Shelton, Connecticut 06484 Indicate by c ...
NanoViricides unveils new data showing lead drug asset's strong activity against RSV
Proactive Investors· 2024-05-14 12:44
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...
NanoViricides CEO discusses NV-387's broad-spectrum antiviral potential
Proactive Investors· 2024-05-13 19:21
NanoViricides (NYSE-A:NNVC) has released a slew of new data supporting the safety and ultra-broad antiviral activity of its investigational therapeutic NV-387. NV-387 was also shown to be effective against the orthopoxvirus family of viruses, which include Smallpox and Mpox, in both inhalation and skin abrasion modes of transmission. In a lethal animal model of lung infection by the Ectromelia virus, a model for Smallpox and Mpox infection in humans, NV-387 led to an increase in the mice's lifespan comparab ...